Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 06:46 PM EDT
Enliven Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -100.22M | -94.83M | -89.02M | -85.21M | -82.83M | -79.6M | -71.58M | -20.03M | -9.81M | -1.98M | 4.07M | -36.5M | -39.6M | -43.87M | -45.46M | -48.58M | -47.36M | -44.4M |
Depreciation & Amortization | 388K | 312K | 317K | 314K | 312K | 308K | 296K | 283K | 265K | 243K | 215K | 184K | 148K | 121K | 107K | 97K | 98K | 98K |
Stock-Based Compensation | 25.04M | 22.46M | 20.17M | 17.89M | 16.12M | 15.17M | 12.91M | 10.59M | 8.29M | 4.8M | 3.19M | 3.07M | 2.98M | 3.19M | 3.48M | 3.55M | 3.19M | 2.82M |
Other Working Capital | 1.5M | -1.28M | -5.35M | 1.91M | 1.6M | 5.8M | 3.65M | -1.87M | -6.77M | -7.77M | 341K | 106K | 2.11M | 3.89M | -103K | 1.51M | 780K | -741K |
Other Non-Cash Items | 2.16M | 440K | -182K | 1.21M | -1.2M | -707K | 1.78M | -35.21M | -33.43M | -32.57M | -32.85M | 2.88M | 4.07M | 5.42M | 3.81M | 2.79M | 1.52M | 139K |
Deferred Income Tax | n/a | n/a | n/a | -4.17M | -4.17M | -4.17M | -6.08M | -2.52M | -803.8K | -833.8K | 1.07M | 1.69M | -30K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.05M | -2.34M | -4.48M | 1.5M | -403K | 5.21M | 1.4M | -3.78M | -5.73M | -5.95M | 114K | 980K | 1.48M | 2.29M | 883K | 2.1M | 1.86M | 423K |
Operating Cash Flow | -70.58M | -73.96M | -73.19M | -68.47M | -72.17M | -63.79M | -61.27M | -50.67M | -41.22M | -36.3M | -25.81M | -30.53M | -34.98M | -38.22M | -40.88M | -42.55M | -42M | -40.89M |
Capital Expenditures | -181K | -44K | -44K | -58K | -52K | -138K | -149K | -236K | -234K | -449K | -612K | -568K | -554K | -251K | -69K | -8K | -8K | -15K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -40M | -40M | -40M | -5M | 35M | 35M | 35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -650.15M | -530.79M | -528.35M | -453.13M | -294.44M | -325.04M | -268.26M | -261.96M | -186.43M | -35M | -35M | -17.79M | -40.02M | -43.84M | -47.56M | -38.16M | -29.91M | -26.1M |
Sales Maturities Of Investments | 431.32M | 451.75M | 429.99M | 392.75M | 236.08M | 158.91M | 120M | 46.82M | 29.93M | 36.41M | 41.88M | 38.36M | 28.65M | 29.37M | 45.94M | 72.24M | 62.54M | 64.77M |
Other Investing Acitivies | 52.4M | 62.4M | 62.4M | 62.4M | 50M | 39.85M | 39.85M | 74.95M | 11.84M | 5.51M | 42.9K | -35.06M | -11.95M | -5.47M | n/a | n/a | n/a | -41.83M |
Investing Cash Flow | -166.61M | -16.68M | -36M | 1.96M | -48.41M | -166.27M | -148.41M | -145.28M | -109.74M | 41.47M | 41.31M | -568K | -9.39M | -5.7M | 12.8M | 34.07M | 32.62M | -3.17M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 308.86M | 90.48M | 90.75M | 270K | 270K | -2.55M | 234.62M | 232.24M | 232.41M | 235.23M | -1.8M | -902K | -1.07M | -1.07M | -1.48M | n/a | n/a | n/a |
Financial Cash Flow | 259.7M | 43.13M | 133.16M | 93.28M | 91.74M | 87.11M | 234.29M | 232.96M | 233.55M | 236.38M | -655K | -899K | 45.93M | 47.58M | 47.63M | 49.71M | 2.85M | 10.79M |
Net Cash Flow | 22.51M | -47.51M | 23.98M | 26.83M | -28.79M | -142.88M | 24.66M | 37.02M | 82.59M | 241.55M | 14.84M | -31.99M | 1.39M | 3.32M | 19.12M | 40.79M | -6.79M | -33.37M |
Free Cash Flow | -70.76M | -74M | -73.24M | -68.53M | -72.22M | -63.92M | -61.42M | -50.9M | -41.45M | -36.74M | -26.42M | -31.09M | -35.53M | -38.47M | -40.95M | -42.56M | -42.01M | -40.91M |